Limin Zheng

Summary

Country: USA

Publications

  1. pmc Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens
    L Zheng
    TechLab, Inc, 2001 Kraft Dr, Blacksburg, VA 24061, USA
    J Clin Microbiol 42:3837-40. 2004
  2. ncbi Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates
    Limin Zheng
    TechLab, Inc, 2001 Kraft Drive, Blacksburg, VA 24060, USA
    Anaerobe 13:114-20. 2007
  3. pmc Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR
    J S Moncrief
    TechLab, Inc, Blacksburg, Virginia 24060 6364, USA
    J Clin Microbiol 38:3072-5. 2000

Detail Information

Publications3

  1. pmc Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens
    L Zheng
    TechLab, Inc, 2001 Kraft Dr, Blacksburg, VA 24061, USA
    J Clin Microbiol 42:3837-40. 2004
    ..We evaluated C. DIFF CHEK, a new screening test that detects glutamate dehydrogenase of C. difficile. Our results showed that this test was comparable to PCR in sensitivity and specificity and outperformed bacterial culture...
  2. ncbi Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates
    Limin Zheng
    TechLab, Inc, 2001 Kraft Drive, Blacksburg, VA 24060, USA
    Anaerobe 13:114-20. 2007
    ..None of the strains was resistant to vancomycin or metronidazole. Imipenem-resistance decreased by EDTA, but susceptibility to meropenem suggests the presence of an imipenem specific metalloenzyme...
  3. pmc Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR
    J S Moncrief
    TechLab, Inc, Blacksburg, Virginia 24060 6364, USA
    J Clin Microbiol 38:3072-5. 2000
    ..Toxin A-negative, toxin B-positive isolates have recently been associated with disease in humans, and they may be more common than was previously supposed...